Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Madrigal Pharmaceuticals Inc (NQ: MDGL ) 212.43 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Madrigal Pharmaceuticals Inc 6 Stocks Positioned to Soar as Investors Focus on MASH April 22, 2024 Investors are making a lot of money on obesity plays. Obesity is at epidemic proportions, so it's easy to see why obesity drugs including GLP-1 agonists have exploded in the marketplace. This class of... Via TheNewswire.com 7 Stocks That Will Drive the Weight Loss Drugs Market March 28, 2024 The booming weight loss drug market presents both lucrative potential and significant risks for investors seeking to capitalize on the global obesity crisis. Via MarketBeat Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/15 Morning Trading March 15, 2024 Via Investor Brand Network Analysts see over 50% gains in these 2 mid-cap biotech stocks February 14, 2024 The outlook for growth has made biotech one of the hottest investments of late - and Wall Street sees big comeback gains ahead in these two biotechs. Via MarketBeat Topics Artificial Intelligence Exposures Artificial Intelligence COVID-19 Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 9/13 Morning Trading September 13, 2023 Via Investor Brand Network Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is a Leading Gainer in 3/17 Morning Trading March 17, 2023 Via Investor Brand Network Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday Session May 23, 2023 Via Investor Brand Network Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) Making Surprising Moves in Tuesday Session April 18, 2023 Via Investor Brand Network Want Diversified Upside in Biotechnology? Check out LABU March 22, 2023 Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility. Via MarketBeat Topics ETFs Stocks Exposures US Equities Why Did Viking Therapeutics Stock Skyrocket December 21, 2022 VKTX stock is young but strong and they have excellent potential, particularly following successful trial results from Madrigal Pharma's recent drug trial. Via MarketBeat Madrigal Pharmaceuticals (NASDAQ: MDGL) Reports Impressive Topline Results from Phase 3 Trial of Resmetirom to Treat NASH and Liver Fibrosis December 19, 2022 Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is engaged as a clinical-stage biopharmaceutical company, which is focused on the research and development Via Spotlight Growth Madrigal Pharmaceuticals Stock Is Up 200% In One Day, Here's Why December 19, 2022 Madrigal Pharmaceuticals announced positive results for a major clinical trial and shares are up more than 200% because of it. Via MarketBeat Exposures Product Safety Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.